Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units

Intensive Care Medicine

Volumn 39, Issue 4, 2013, Pages 653-660

  Oostdijk, Evelien A N ^a   Smits, Loek ^a   De Smet, Anne Marie G A ^b   Leverstein Van Hall, Maurine A ^a,c,d   Kesecioglu, Jozef ^a   Bonten, Marc J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

Antibiotic resistance; Intensive care; Polymyxin E; SDD; Selective decontamination; SOD

Indexed keywords

COLISTIN; TOBRAMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASEPSIS; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; COHORT ANALYSIS; GENOTYPE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEALTH CARE; HUMAN; INFECTION PREVENTION; INFORMATION PROCESSING; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NONHUMAN; PHYSICAL EXAMINATION; PSEUDOMONAS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT EXAMINATION; RISK FACTOR; SELECTIVE DIGESTIVE DECONTAMINATION; SELECTIVE OROPHARYNGEAL DECONTAMINATION;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; COHORT STUDIES; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GASTROINTESTINAL TRACT; GENOTYPE; GRAM-NEGATIVE BACTERIA; HUMANS; INTENSIVE CARE UNITS; MULTICENTER STUDIES AS TOPIC; NETHERLANDS; OROPHARYNX; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTUM;

EID: 84884212758     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2761-3     Document Type: Article

References (26)

1. Li J, Nation RL (2006) Old polymyxins are back: is resistance close? Clin Infect Dis 43:663-664
2. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL (2006) Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 6:589-601
3. Livermore DM (2009) Has the era of untreatable infections arrived? J Antimicrob Chemother 64(Suppl 1):i29-i36
4. Hirsch EB, Tam VH (2010) Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 65:1119-1125
5. Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228-236
6. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1-12
7. Bonten MJ, Kullberg BJ, van Dalen R, Girbes AR, Hoepelman IM, Hustinx W, van der Meer JW, Speelman P, Stobberingh EE, Verbrugh HA, Verhoef J, Zwaveling JH (2000) Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy. J Antimicrob Chemother 46:351-362
8. Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF (1984) The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med 10:185-192
9. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, Bernards AT, Kuijper EJ, Joore JC, Leverstein-van Hall MA, Bindels AJ, Jansz AR, Wesselink RM, de Jongh BM, Dennesen PJ, van Asselt GJ, te Velde LF, Frenay IH, Kaasjager K, Bosch FH, van Iterson M, Thijsen SF, Kluge GH, Pauw W, de Vries JW, Kaan JA, Arends JP, Aarts LP, Sturm PD, Harinck HI, Voss A, Uijtendaal EV, Blok HE, Thieme Groen ES, Pouw ME, Kalkman CJ, Bonten MJ (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360:20-31
10. Zavascki AP, Goldani LZ, Li J, Nation RL (2007) Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 60:1206-1215
11. Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski A 3rd, Forrest A, Bulitta JB, Tsuji BT (2010) Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy 30:1279-1291
12. Fluit AC, Terlingen AM, Andriessen L, Ikawaty R, van Mansfeld R, Top J, Cohen Stuart JW, Leverstein-van Hall MA, Boel CH (2010) Evaluation of the DiversiLab system for detection of hospital outbreaks of infections by different bacterial species. J Clin Microbiol 48:3979-3989
13. Grisold AJ, Zarfel G, Strenger V, Feierl G, Leitner E, Masoud L, Hoenigl M, Raggam RB, Dosch V, Marth E (2010) Use of automated repetitive-sequence-based PCR for rapid laboratory confirmation of nosocomial outbreaks. J Infect 60:44-51
14. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, Kesecioglu J (2003) Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362:1011-1016
15. Vincent JL, Jacobs F (2011) Effect of selective decontamination on antibiotic resistance. Lancet Infect Dis 11:337-338
16. Krueger WA, Lenhart FP, Neeser G, Ruckdeschel G, Schreckhase H, Eissner HJ, Forst H, Eckart J, Peter K, Unertl KE (2002) Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 166:1029-1037
17. Antoniadou A, Kontopidou F, Poulakou G, Koratzanis E, Galani I, Papadomichelakis E, Kopterides P, Souli M, Armaganidis A, Giamarellou H (2007) Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother 59:786-790
18. Matthaiou DK, Michalopoulos A, Rafailidis PI, Karageorgopoulos DE, Papaioannou V, Ntani G, Samonis G, Falagas ME (2008) Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med 36:807-811
19. Mentzelopoulos SD, Pratikaki M, Platsouka E, Kraniotaki H, Zervakis D, Koutsoukou A, Nanas S, Paniara O, Roussos C, Giamarellos-Bourboulis E, Routsi C, Zakynthinos SG (2007) Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa. Intensive Care Med 33:1524-1532
20. Ong DS, Jongerden IP, Buiting AG, Leverstein-van Hall MA, Speelberg B, Kesecioglu J, Bonten MJ (2011) Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units. Crit Care Med 39:2458-2463
21. de Smet AM, Kluytmans JA, Blok HE, Mascini EM, Benus RF, Bernards AT, Kuijper EJ, Leverstein-van Hall MA, Jansz AR, de Jongh BM, van Asselt GJ, Frenay IH, Thijsen SF, Conijn SN, Kaan JA, Arends JP, Sturm PD, Bootsma MC, Bonten MJ (2011) Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis 11:372-380
22. Lo-Ten-Foe JR, de Smet AM, Diederen BM, Kluytmans JA, van Keulen PH (2007) Comparative evaluation of the VITEK 2, disk diffusion, e test, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 51:3726-3730
23. Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Besbes M, Meakins JL, Soussy CJ, Lemaire F (1989) Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 110:873-881
24. Buehlmann M, Bruderer T, Frei R, Widmer AF (2011) Effectiveness of a new decolonisation regimen for eradication of extended-spectrum beta-lactamase- producing Enterobacteriaceae. J Hosp Infect 77:113-117
25. Perez F, Pultz MJ, Endimiani A, Bonomo RA, Donskey CJ (2011) Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice. Antimicrob Agents Chemother 55:2585-2589
26. Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A (2005) Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 33:309-313